Funded Tech Companies
Sigilon Therapeutics
Wondering who backed Sigilon Therapeutics? Eli Lilly and Company, BlackRock and Flagship Pioneering put venture money into this biopharmaceutical company.
Company Overview
Company Name
Sigilon Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Binney St. 600
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Sigilon Therapeutics (Nasdaq: SGTX) was founded and created by Flagship Pioneering. Sigilon Therapeutics is developing treatments for chronic diseases using new biomaterials, developed at the Massachusetts Institute of Technology (MIT), that can shield implanted cells from immune attack.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/3/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rogerio Vivaldi
Chief Financial Officer
Glenn Reicin
Chief Medical Officer
Deya Corzo
Chief Technical Officer
David Peritt
Vice President
Hozefa Bandukwala
Vice President
Olivia Kelly
VP - Bus. Development
Anne Altmeyer
VP - Engineering
Susan Drapeau
VP - Finance
Josias Pontes
VP - General Counsel
Melodie Henderson
VP - General Counsel
Matthew Kowalsky
VP - Human Resources
Vanya Sagar
VP - Manufacturing
Martha Rook
VP - Operations
Devyn Smith
Company Investors
- Eli Lilly and Company
- BlackRock
- Flagship Pioneering (Douglas Cole)
- Longevity Fund
- Canada Pension Plan Investment Board
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs